ENDRA Life Sciences PE Ratio 2017-2024 | NDRA
Current and historical p/e ratio for ENDRA Life Sciences (NDRA) from 2017 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ENDRA Life Sciences PE ratio as of September 10, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ENDRA Life Sciences PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-09-11 | 0.25 | 0.00 | |
| 2024-06-30 | 4.86 | $-45.50 | 0.00 |
| 2024-03-31 | 29.00 | $-63.00 | 0.00 |
| 2023-12-31 | 106.00 | $-96.50 | 0.00 |
| 2023-09-30 | 55.51 | $-140.00 | 0.00 |
| 2023-06-30 | 70.00 | $-170.00 | 0.00 |
| 2023-03-31 | 114.50 | $-208.50 | 0.00 |
| 2022-12-31 | 203.50 | $-232.00 | 0.00 |
| 2022-09-30 | 306.00 | $-250.00 | 0.00 |
| 2022-06-30 | 233.20 | $-260.00 | 0.00 |
| 2022-03-31 | 390.00 | $-280.00 | 0.00 |
| 2021-12-31 | 691.80 | $-270.00 | 0.00 |
| 2021-09-30 | 1730.00 | $-300.00 | 0.00 |
| 2021-06-30 | 2180.00 | $-390.00 | 0.00 |
| 2021-03-31 | 2600.00 | $-510.00 | 0.00 |
| 2020-12-31 | 750.00 | $-740.00 | 0.00 |
| 2020-09-30 | 731.50 | $-1,840.00 | 0.00 |
| 2020-06-30 | 962.40 | $-2,150.00 | 0.00 |
| 2020-03-31 | 722.20 | $-2,260.00 | 0.00 |
| 2019-12-31 | 1680.00 | $-2,340.00 | 0.00 |
| 2019-09-30 | 1060.00 | $-1,420.00 | 0.00 |
| 2019-06-30 | 1710.00 | $-1,660.00 | 0.00 |
| 2019-03-31 | 1660.00 | $-1,820.00 | 0.00 |
| 2018-12-31 | 1500.00 | $-2,170.00 | 0.00 |
| 2018-09-30 | 3060.00 | $-2,540.00 | 0.00 |
| 2018-06-30 | 2550.00 | $-2,070.00 | 0.00 |
| 2018-03-31 | 2600.00 | $-2,190.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $238.445B | 28.58 |
| Intuitive Surgical (ISRG) | United States | $172.077B | 97.43 |
| Alcon (ALC) | Switzerland | $48.397B | 34.07 |
| IQVIA Holdings (IQV) | United States | $42.877B | 24.30 |
| IDEXX Laboratories (IDXX) | United States | $40.820B | 49.10 |
| Edwards Lifesciences (EW) | United States | $40.445B | 25.92 |
| DexCom (DXCM) | United States | $27.470B | 39.17 |
| STERIS (STE) | Ireland | $24.375B | 28.44 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.978B | 0.00 |
| Waters (WAT) | United States | $19.480B | 29.04 |
| Hologic (HOLX) | United States | $19.037B | 20.70 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.206B | 13.68 |
| Sysmex ADR (SSMXY) | Japan | $12.159B | 38.13 |
| Teleflex (TFX) | United States | $11.629B | 18.08 |
| Globus Medical (GMED) | United States | $9.395B | 26.28 |
| Penumbra (PEN) | United States | $7.929B | 82.31 |
| Glaukos (GKOS) | United States | $6.909B | 0.00 |
| Masimo (MASI) | United States | $6.117B | 32.76 |
| TransMedics (TMDX) | United States | $4.526B | 193.83 |
| Integer Holdings (ITGR) | United States | $4.130B | 24.15 |
| PROCEPT BioRobotics (PRCT) | United States | $3.996B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.684B | 0.00 |
| Inari Medical (NARI) | United States | $2.610B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.551B | 14.97 |
| Nihon Kohden (NHNKY) | Japan | $2.506B | 15.60 |
| Elekta AB (EKTAY) | Sweden | $2.328B | 18.97 |
| Veracyte (VCYT) | United States | $2.284B | 141.62 |
| RxSight (RXST) | United States | $1.977B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.375B | 6.26 |
| OPKO Health (OPK) | United States | $1.109B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.105B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.099B | 19.60 |
| Pulse Biosciences (PLSE) | United States | $1.056B | 0.00 |
| Artivion (AORT) | United States | $1.024B | 94.00 |
| Alphatec Holdings (ATEC) | United States | $0.782B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.741B | 0.00 |
| SiBone (SIBN) | United States | $0.654B | 0.00 |
| Paragon 28 (FNA) | United States | $0.645B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.643B | 16.23 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.624B | 0.00 |
| IRadimed (IRMD) | United States | $0.594B | 32.09 |
| AxoGen (AXGN) | United States | $0.577B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.474B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.333B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.325B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.322B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.315B | 9.60 |
| AngioDynamics (ANGO) | United States | $0.298B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.274B | 0.00 |
| Inogen (INGN) | United States | $0.267B | 0.00 |
| NeuroPace (NPCE) | United States | $0.207B | 0.00 |
| Accuray (ARAY) | United States | $0.201B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.184B | 0.00 |
| Nevro (NVRO) | United States | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.164B | 11.52 |
| Alpha Tau Medical (DRTS) | Israel | $0.161B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.135B | 0.00 |
| 908 Devices (MASS) | United States | $0.122B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.119B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.115B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.096B | 14.24 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.070B | 0.00 |
| Envoy Medical (COCH) | United States | $0.062B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 0.00 |
| LENSAR (LNSR) | United States | $0.054B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.044B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.043B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.038B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.033B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.029B | 0.00 |
| ReWalk Robotics (LFWD) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Neuronetics (STIM) | United States | $0.024B | 0.00 |
| Spectral AI (MDAI) | United States | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.020B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.020B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.015B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |